Dr. Michael K. Hehir II, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Rochester School of Medicine and Dentistry (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 320
Licensed in Vermont since 2011, according to the Vermont Board of Medical Practice. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Rochester School of Medicine and Dentistry
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
VT license 042-0012198 (first issued 2011; active) -
Electrodiagnostic Medicine Physician
VT license 042-0012198 (first issued 2011; active) -
Neuromuscular Medicine (Psychiatry & Neurology) Physician
VT license 042-0012198 (first issued 2011; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Univ. of Vermont - Fletcher Allen Health Care Burlington, VT
- The University of Vermont Health Network - Champl Plattsburgh, NY
- Northwestern Medical Center Inc Saint Albans, VT
- Porter Hospital Inc Middlebury, VT
- Rutland Regional Medical Center Rutland, VT
Medical groups
- University of Vermont Medical Center Inc (1,208 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 320
- Services billed
- 835
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 157 | 123 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 50 | 49 |
| Established patient office or other outpatient visit, 40-54 minutes | 47 | 40 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 39 | 33 |
| Established patient office or other outpatient visit, 20-29 minutes | 32 | 31 |
| Nerve conduction, 5-6 studies | 23 | 23 |
| Nerve conduction, 3-4 studies | 18 | 17 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
| New patient office or other outpatient visit, 60-74 minutes | 17 | 17 |
| Nerve conduction, 7-8 studies | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pyridostigmine Bromide Other prescribers in Burlington, VT | 143 |
| Prednisone Other prescribers in Burlington, VT | 127 |
| Mycophenolate Mofetil Other prescribers in Burlington, VT | 106 |
| Gammaked (immune globul g/gly/iga avg 46) | 70 |
| Duloxetine Hcl Other prescribers in Burlington, VT | 58 |
| Pregabalin Other prescribers in Burlington, VT | 54 |
| Gabapentin Other prescribers in Burlington, VT | 51 |
| Gamunex-C (immune globul g/gly/iga avg 46) | 48 |
| Gammagard Liquid (immun glob g(igg)/gly/iga ov50) | 37 |
| Lamotrigine Other prescribers in Burlington, VT | 23 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 14 payments worth $42,819 in total to this clinician.
| Argenx US, Inc. | $38,571 |
|---|---|
| UCB, Inc. | $3,658 |
| Amgen Inc. | $590 |
| Consulting Fee | $42,416 |
|---|---|
| Food and Beverage | $403 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Argenx US, Inc. Jul 23, 2025 | Consulting Fee VYVGART · Immunology | $21,400 |
| Argenx US, Inc. Mar 3, 2025 | Consulting Fee VYVGART HYTRULO · Neurology | $10,500 |
| Argenx US, Inc. Nov 20, 2025 | Consulting Fee VYVGART HYTRULO · Neurology | $2,500 |
| Argenx US, Inc. Nov 19, 2025 | Consulting Fee VYVGART · Immunology | $2,500 |
| UCB, Inc. Sep 18, 2025 | Consulting Fee | $1,600 |
| Argenx US, Inc. Jul 25, 2025 | Consulting Fee | $1,406 |
| UCB, Inc. Sep 9, 2025 | Consulting Fee | $1,280 |
| UCB, Inc. Jun 20, 2025 | Consulting Fee Zilbrysq · Neurology | $640 |
| Amgen Inc. May 20, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $590 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.